chr22-40056115-T-C

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NM_001024843.2(TNRC6B):c.-121+11117T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. Note: NM_001024843.2 is not a MANE Select or MANE Plus Clinical transcript for TNRC6B; the reported annotation may differ from that of the MANE-designated reference transcript for this gene. The variant allele was found at a cumulative frequency of 0.368 (AC=55,958) in the gnomAD database across 152,086 control chromosomes, including 15,089 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.758. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.37 ( 15089 hom., cov: 32)

Consequence

TNRC6B
NM_001024843.2 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.03

Publications

1 publications found
Variant links:
Genes affected
TNRC6B (HGNC:29190): (trinucleotide repeat containing adaptor 6B) Enables RNA binding activity. Involved in positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; and regulatory ncRNA-mediated gene silencing. Acts upstream of with a positive effect on miRNA-mediated gene silencing by inhibition of translation. Predicted to be located in cytosol. Predicted to be active in P-body and nucleoplasm. Implicated in subserous uterine fibroid and uterine fibroid. [provided by Alliance of Genome Resources, Jul 2025]
TNRC6B Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • global developmental delay with speech and behavioral abnormalities
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001024843.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Benign. The variant received -12 points.

BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); No splicing predictor data available.; Germline computational verdict: benign (Strong).
BA1Stand-alone benign allele frequency (>5%)
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.7581 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001024843.2. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

TNRC6B NM_001024843.2
HGVSc / HGVSpc.-121+11117T>C
Exon rankIntron 1 of 23
intron
Prot: NP_001020014.1UniProt: Q9UPQ9-2

Ensembl Transcripts

TNRC6B ENST00000402203.5
TSL:1
HGVSc / HGVSpc.-121+10527T>C
Exon rankIntron 1 of 23
intron
Prot: ENSP00000384795.1UniProt: Q9UPQ9-2
TNRC6B ENST00000301923.13
TSL:5
HGVSc / HGVSpc.-121+11117T>C
Exon rankIntron 1 of 23
intron
Prot: ENSP00000306759.9UniProt: Q9UPQ9-2

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
AF: 0.368
AC:55852
Hom:15035
AN:151968
Cov:32
GnomAD4 genome
AF: 0.368
AC:55958
Hom:15089
AN:152086
Cov:32
TOPMed (Bravo)
AF: 0.383
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.263
AC:154294
Hom:27179
AN:587204
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.303
AC:710
Hom:136
AN:2342
ChinaMAP Phase 1
AF: 0.0392
Denmark Genome
AF: 0.203
AC:61
AN:300
GenomeAsia100K
AF: 0.235
AC:818
AN:3478
Korea4K (4,157 Koreans)
AF: 0.0410
AC:298
AN:7232
Qatari Genome
AF: 0.375
AC:66
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.0317
AC:3891
Hom:77
AN:122692
Turkish Variome
AF: 0.268
AC:415
Hom:65
AN:1546
UK10K
AF: 0.229
AC:1734
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.0317
AC:284
Hom:3
AN:8960
Showing 14 sources
Tested, but no data found:GnomAD4 exomeIf GnomAD4 is missing, the position is probably not covered by the project.

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign2.1
BayesDel_noAF
Benign-0.98
CADD
Benign0.19
DANN
Benign0.42
GPN-Star LLR
N/A4.3
GPN-Star score
N/A-0.092
Mutation Taster
N/A100/0polymorphism (auto)
PhyloP100
Benign-2.0
Showing 8 of 8 scores

Splicing Scores

Pangolin (max)
Benign0.0
Showing 1 of 1 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.